Found 257 matching trials
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide PHASE2 Historically, the best results of allogeneic SCT have been obtained when th...
Show More Location
Loyola University Medical Center
Learn More & Join Trial
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma PHASE2 The purpose of this trial is to develop an alternative treatment for patien...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT PHASE1 The major morbidities of allogeneic hematopoietic stem cell transplant (HSC...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer PHASE2 RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Show More Location
Multiple Locations
Learn More & Join Trial
HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation PHASE3 The MAC-HAPLO-MUD trial is a randomized prospective phase III trial compari...
Show More Location
Multiple Locations
Learn More & Join Trial
Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia PHASE1 The purpose of this research study is to look at overall health status and ...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation EARLY_PHASE1 This research study is to determine if donor blood stem cells given after l...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant PHASE1 This phase I/II trial studies the best dose of sorafenib when given togethe...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors PHASE2 The purpose of this study is to find out if removing a specific type of whi...
Show More Location
Memorial SloanKettering Cancer Center
Learn More & Join Trial
Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission N/A The purpose of this study is to evaluate the effect of various clinical var...
Show More Location
Asan Medical Center
Learn More & Join Trial